DNP Acquires Controlled Medical Devices Retailer License at Tanabe Plant
Will put medical-related packaging, storage and sales ops on nationwide basis
Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the acquisition at the Tanabe plant in Kyoto of a license as a Controlled Medical Devices (Retailer), allowing the Company to market such controlled devices as blood collection kits and clinical electronic thermometers. In Japan, it is necessary to obtain permission from local authorities when manufacturing or shipping medical devices and/or pharmaceuticals. The DNP Tanabe plant had previously acquired a Manufacturer (Packaging, Labelling and Storage) license, sanctioning the production of medical device manuals and their insertion in packing alongside the said device. And by combining that license with the newly acquired Controlled Medical Devices (Retailer) license it will now be possible for the Company to offer a total response, from purchasing controlled medical devices from manufacturers, packing with manuals and, directly delivering the result to retail distributors.
[Background and Operations]
DNP has positioned Knowledge and Communications, Food and Healthcare, the Environment and Energy, and Lifestyle and Mobility as growth areas, and is engaged in proposing new values to consumers and companies. In the Food and Healthcare area, alongside packaging for foods and daily necessities, the Company is also involved in the printing of manuals that are included in pharmaceutical packing.
Based on the February 2014 enforcement of the Industrial Competitiveness Enhancement Act, a System to Remove Grey Zone Areas has also been implemented. This helps provide legal confirmation for the right of non-medically licensed individuals to collect their own blood samples, and as a result, medical device makers have commenced marketing blood collection kits allowing such individuals to collect and test their own blood. Blood collection kits allow consumers who may not have the chance to visit healthcare centers, to collect blood in their own homes in a carefree manner. At the same time however, it is necessary to properly convey usage methods to the consumer, and this means that such devices have been designated as Controlled Medical Devices by the Ministry of Health, Labour and Welfare
For their part, pharmaceutical and medical device makers have called for unified responses that allow for the device and the accompanying manual to be packed in a set, as this helps reduce operational tasks.
In answer to these needs, DNP has acquired a Controlled Medical Devices (Retailer) license. And as a result of this acquisition, by combining the new license with the previously acquired Manufacturer (Packaging, Labelling and Storage) license, it will be possible for the Company to offer a total sales operation from purchasing controlled medical devices, including blood collection kits, from manufacturers, packing them with manuals and directly delivering them to retail distributors.
Apart from the Tanabe plant, DNP bases in four locations, including Tokyo and Nagoya have also acquired licenses allowing them to pack and store pharmaceuticals and medical devices. The Company will capitalize on the clean manufacturing environment provided by these locations to expand operations.
DNP will operate a unified business from the printing of pharmaceutical and medical devices packaging, along with storage and packing, aiming for sales of 300 million yen by FY 2017.